|
⚲
|
| Keyboard |
| Hepner Adrian
✚
|
|
|---|---|
| CIK # | 0001637347 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001637347] | |
| 4 | [0001637347] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hepner Adrian | |
| Coya Therapeutics Inc | |
| Eagle Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Coya Therapeutics Inc COYA
Stock Option (right to buy) · derivative
|
2023-02-27 | Grant | 115,000 | $0.00 | |
|
Coya Therapeutics Inc COYA
Warrant to Purchase Common Stock · derivative
|
2023-01-03 | Buy | 5,000 | ||
|
Coya Therapeutics Inc COYA
Common Stock, par value $0.0001 per share
|
2023-01-03 | Buy | 10,000 | ||
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2020-01-23 | Tax withheld | 1,630 | $57.98 | 94,507 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2020-01-07 | Tax withheld | 815 | $57.38 | 46,765 |
|
Eagle Pharmaceuticals Inc EGRX
Employee Stock Option (right to buy) · derivative
|
2020-01-05 | Grant | 55,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2020-01-05 | Grant | 24,000 | ||
|
Eagle Pharmaceuticals Inc EGRX
Employee Stock Option (right to buy) · derivative
|
2019-01-23 | Grant | 42,500 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2019-01-23 | Grant | 19,000 | ||
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2019-01-07 | Tax withheld | 771 | $41.33 | 31,865 |
|
Eagle Pharmaceuticals Inc EGRX
Performance Stock Unit · derivative
|
2018-01-07 | Grant | 27,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Employee Stock Option (Right to Buy) · derivative
|
2018-01-07 | Grant | 43,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock
|
2018-01-07 | Grant | 9,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-01-04 | Grant | 67,200 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2016-01-04 | Grant | 62,100 | $0.00 |